Lifecome Biochemistry Co.,Ltd. (SHE:002868)

Lifecome Biochemistry Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.97	24.8	84.38	23.76	97.5	194.26
Cash & Short-Term Investments	10.97	24.8	84.38	23.76	97.5	194.26
Cash Growth	-24.46%	-70.61%	255.14%	-75.63%	-49.81%	-55.58%
Accounts Receivable	50.36	76.83	128.42	60.06	44.86	34.12
Other Receivables	15.57	17.52	59.82	2.76	19.56	17.88
Receivables	65.93	94.36	188.24	62.82	64.42	52.01
Inventory	108	95.71	201.89	89.06	61.2	53.53
Other Current Assets	0.97	1.36	3.87	330.16	4.86	4.78
Total Current Assets	185.88	216.22	478.39	505.8	227.97	304.58
Property, Plant & Equipment	993.83	1,062	1,150	633.54	907.87	512.03
Long-Term Investments	57.16	51.65	44.75	48.57	59.14	81.09
Goodwill	-	-	61.6	-	-	-
Other Intangible Assets	118.32	125.58	132.21	31.4	40.86	42.08
Long-Term Deferred Tax Assets	11	11.05	30.96	7.47	9.15	2.67
Long-Term Deferred Charges	11.06	12.49	0.8	0.19	2.03	-
Other Long-Term Assets	7.02	12.49	66.79	12.9	11.39	30.06
Total Assets	1,384	1,492	1,965	1,240	1,258	972.5
Accounts Payable	329.85	315.72	310.09	136.11	167.7	80.38
Accrued Expenses	9.14	17.12	12.56	7.95	9.79	9.43
Short-Term Debt	337.87	296.76	387.77	202.93	156.28	5.01
Current Portion of Long-Term Debt	578.53	479.08	85.47	41.71	37.16	20.07
Current Portion of Leases	-	4.36	1.31	0.08	0.07	-
Current Income Taxes Payable	6.67	-	-	-	-	1.98
Current Unearned Revenue	9.19	17.06	1.51	2.81	0.91	3.63
Other Current Liabilities	8.09	112.6	131.61	93.54	18.42	6.33
Total Current Liabilities	1,279	1,243	930.31	485.14	390.34	126.82
Long-Term Debt	86.88	133.92	490.25	105.88	96.99	57
Long-Term Leases	91.85	106.1	121.9	45	30.69	-
Long-Term Unearned Revenue	27.65	30.02	3.47	4.32	9.63	10.51
Long-Term Deferred Tax Liabilities	3.05	3.46	4.96	0.22	8.73	8.23
Total Liabilities	1,489	1,516	1,551	640.56	536.38	202.56
Common Stock	155.42	155.42	155.42	155.42	155.42	155.42
Additional Paid-In Capital	351.95	349.47	345.46	340.47	340.47	340.47
Retained Earnings	-620.95	-538.36	-93.5	128.32	250.26	297.78
Treasury Stock	-	-	-	-32.43	-32.43	-32.43
Comprehensive Income & Other	7.2	7.2	3.91	3.91	3.91	3.91
Total Common Equity	-106.38	-26.27	411.29	595.69	717.63	765.15
Minority Interest	1.86	1.73	2.82	3.61	4.4	4.8
Shareholders' Equity	-104.52	-24.54	414.11	599.3	722.02	769.94
Total Liabilities & Equity	1,384	1,492	1,965	1,240	1,258	972.5
Total Debt	1,095	1,020	1,087	395.6	321.19	82.08
Net Cash (Debt)	-1,084	-995.43	-1,002	-371.84	-223.7	112.19
Net Cash Growth	-	-	-	-	-	-64.44%
Net Cash Per Share	-6.96	-6.40	-6.51	-2.41	-1.46	0.73
Filing Date Shares Outstanding	155.42	155.42	155.42	153.4	153.4	153.4
Total Common Shares Outstanding	155.42	155.42	155.42	153.4	153.4	153.4
Working Capital	-1,093	-1,026	-451.92	20.66	-162.36	177.76
Book Value Per Share	-0.68	-0.17	2.65	3.88	4.68	4.99
Tangible Book Value	-224.7	-151.84	217.48	564.29	676.77	723.07
Tangible Book Value Per Share	-1.45	-0.98	1.40	3.68	4.41	4.71
Buildings	-	543.18	479.28	406.53	206.45	194.69
Machinery	-	890.18	657.2	585.29	310.2	290.91
Construction In Progress	-	55.9	410.78	6.2	709.64	315.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.